Target Corporation Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts

Manufacturer
Target Corporation
Effective date
2019-12-12
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 23:52:34

Label at a glance#

ProductUp and Up Naproxen Sodium
Active ingredientNAPROXEN SODIUM
Label structure9 sections

Indications and uses

• temporarily relieves minor aches and pains due to: • minor pain of arthritis • muscular aches • backache • menstrual cramps • headache • toothache • the common cold • temporarily reduces fever

Dosage and administration

• do not take more than directed • the smallest effective dose should be used • drink a full glass of water with each dose • if taken with food, this product may take longer to work adults and children 12 years and older: • take 1 capsule every 8 to 12 hours while symptoms last • for the first dose you may take 2 capsules within the first hour • do not exceed 2 capsules in any 8- to 12-hour period • do not exceed ...

Storage and handling

• each capsule contains: sodium 20 mg • store at 20-25°C (68-77°F) avoid high humidity and excessive heat above 40°C (104°F) • do not use if printed foil under cap is broken or missing • read all directions and warnings before use. Keep carton.

Label contents#

Full prescribing information#

Active ingredient (in each capsule)

OTC - ACTIVE INGREDIENT SECTION

Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to:
  • minor pain of arthritis
  • muscular aches
  • backache
  • menstrual cramps
  • headache
  • toothache
  • the common cold
  • temporarily reduces fever

Warnings

WARNINGS SECTION

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock
  • skin reddening
  • rash
  • blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Do not use

OTC - DO NOT USE SECTION

  • if you have ever had an allergic reaction to any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • the stomach bleeding warning applies to you
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, or kidney disease
  • you are taking a diuretic
  • you have problems or serious side effects from taking pain relievers or fever reducers
  • you have asthma

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • under a doctor’s care for any serious condition
  • taking any other drug

When using this product

OTC - WHEN USING SECTION

  • take with food or milk if stomach upset occurs
  • the risk of heart attack or stroke may increase if you use more than directed or for longer than directed

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
  • feel faint
  • vomit blood
  • have bloody or black stools
  • have stomach pain that does not get better
  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present in the painful area
  • any new symptoms appear
  • you have difficulty swallowing
  • it feels like the capsule is stuck in your throat

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed
  • the smallest effective dose should be used
  • drink a full glass of water with each dose
  • if taken with food, this product may take longer to work

adults and children 12 years and older:

  • take 1 capsule every 8 to 12 hours while symptoms last
  • for the first dose you may take 2 capsules within the first hour
  • do not exceed 2 capsules in any 8- to 12-hour period
  • do not exceed 3 capsules in a 24-hour period

children under 12 years:

  • ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each capsule contains: sodium 20 mg
  • store at 20-25°C (68-77°F) avoid high humidity and excessive heat above 40°C (104°F)
  • do not use if printed foil under cap is broken or missing
  • read all directions and warnings before use. Keep carton.

Inactive ingredients

INACTIVE INGREDIENT SECTION

FD&C blue #1, gelatin, glycerin, lactic acid, mannitol, pharmaceutical ink, polyethylene glycol, povidone, propylene glycol, purified water, sorbitan, sorbitol

Questions?

OTC - QUESTIONS SECTION

Call 1-800-910-6874

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

naproxen sodium capsules, 220 mg (NSAID)

pain reliever/fever reducer

Compare to the active ingredient of Aleve® Liquid Gels

strength to last 12 hours

ACTUAL SIZE

# LIQUID GELS** {Replace "#" with the number of liquidgels in the product}

(**LIQUID-FILLED CAPSULES)

Naproxen Sodium Capsules, 220 mg (NSAID) Carton Image
Naproxen Sodium Capsules, 220 mg (NSAID) Carton Image

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3C2
NAPROXENACTIVE MOIETY57Y76R9ATQ2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD2
GELATININACTIVE INGREDIENT2G86QN327L2
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
LACTIC ACIDINACTIVE INGREDIENT33X04XA5AT2
MANNITOLINACTIVE INGREDIENT3OWL53L36A2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A2
POVIDONESINACTIVE INGREDIENTFZ989GH94E2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
SORBITANINACTIVE INGREDIENT6O92ICV9RU2
SORBITOLINACTIVE INGREDIENT506T60A25R2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11673-74211673-742-27, 11673-742-06, 11673-742-58

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 397 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
37 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATCREAM / TOPICAL1 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION / INTRALESIONAL45 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM / BUCCAL1.48 mgExact identifier — unii candidate
81 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR113 mgExact identifier — unii candidate
65 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / ORAL27120 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / VAGINAL60 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDCAPSULE / ORAL26.3 mgExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, LIQUID FILLED / ORAL185 mgExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ETABLET / SUBLINGUAL6 mgExact identifier — unii candidate
30 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE, DELAYED RELEASE / ORAL1791 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LWAFER / ORALNAExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE, COATED PELLETS / ORAL65 mgExact identifier — unii candidate
44 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ECAPSULE / ORAL300 mgExact identifier — unii candidate
30 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSUSPENSION / ORAL1 mgExact identifier — unii candidate
37 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii candidate
44 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, FOR SUSPENSION / ORAL7621 mgExact identifier — unii candidate
65 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / TOPICAL18144 mgExact identifier — unii candidate
75 equally ranked IID candidates
SORBITOLSORBITOL506T60A25ROINTMENT / TOPICAL10 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LGUM, CHEWING / BUCCAL102 mgExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RLIQUID / ORAL53460 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS1.04 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDCAPSULE, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ESUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET / ORAL46 mgExact identifier — unii candidate
44 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION, CONCENTRATE / INTRAVENOUS220 mgExact identifier — unii candidate
65 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ETABLET, ORALLY DISINTEGRATING / ORAL15.03 mgExact identifier — unii candidate
30 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDLIQUID / ORALNAExact identifier — unii candidate
37 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSHAMPOO / TOPICAL0.75 %w/wExact identifier — unii candidate
37 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ETABLET, CHEWABLE / ORAL48 mgExact identifier — unii candidate
30 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDDOUCHE / VAGINALNAExact identifier — unii candidate
37 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / ORAL6168 mgExact identifier — unii candidate
44 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AGEL / OPHTHALMIC25 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET / SUBLINGUAL495 mgExact identifier — unii candidate
65 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSYSTEM / TOPICAL6300 mgExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER, FOR SOLUTION / ORAL3767 mgExact identifier — unii candidate
65 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION, SUSPENSION / INTRAMUSCULAR1.3 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LPASTE / DENTAL252 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET, DELAYED RELEASE / ORAL19 mgExact identifier — unii candidate
44 equally ranked IID candidates
POVIDONESPOVIDONEFZ989GH94ETABLET / ORAL216 mgExact identifier — unii candidate
30 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCREAM / TOPICAL36.8 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATCREAM / VAGINAL0.81 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER, FOR SUSPENSION / ORAL12000 mgExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCONCENTRATE / ORAL600 mg/1mlExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSOLUTION, CONCENTRATE / ORAL300 mg/1mlExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / ORAL750 mgExact identifier — unii candidate
75 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021920-001NAPROXEN SODIUMNAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021920-001100223442026-03-03U-1731Drug product2018-07-23
N021920-001100223442026-03-03U-1732Drug product2018-07-23
N021920-001100289252026-03-03U-1731Drug product2018-07-24
N021920-001100289252026-03-03U-1732Drug product2018-07-24
N021920-001110902802026-03-03U-1731Drug product2021-08-24
N021920-001110902802026-03-03U-1732Drug product2021-08-24
N021920-00196939782026-03-03Drug product2017-11-13
N021920-00196939792026-03-03Drug product2017-11-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1784e616aacf4f…
2026-08-18 06:07:402026-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-1787673890dc5c…
2021-03-12 10:30 UTC2021-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-175aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-178869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173f01610625f2…
2019-09-15 20:21 UTC2019-09N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17b00525d2431f…
2019-07-19 19:46 UTC2019-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-176a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-171c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-179b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173f0d92c62455…
2023-05-13 08:27 UTC2023-05N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17053a50430f4f…
2023-01-26 05:58 UTC2023-01N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-173a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021920-001NAPROXEN SODIUMEQ 200MG BASECAPSULE / ORALRLD, RS2006-02-17f41ea6bd6efb…

Observed Orange Book patent history#

Patent history page 1 of 9 · 329 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N021920-001100223442026-03-03U-1731Drug product2018-07-2384e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100223442026-03-03U-1732Drug product2018-07-2384e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100289252026-03-03U-1731Drug product2018-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001100289252026-03-03U-1732Drug product2018-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001110902802026-03-03U-1731Drug product2021-08-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-001110902802026-03-03U-1732Drug product2021-08-2484e616aacf4f…
2026-09-14 22:38:342026-08N021920-00196939782026-03-03Drug product2017-11-1384e616aacf4f…
2026-09-14 22:38:342026-08N021920-00196939792026-03-03Drug product2017-11-1384e616aacf4f…
2026-08-18 06:07:402026-07N021920-001100223442026-03-03U-1731Drug product2018-07-23caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100223442026-03-03U-1732Drug product2018-07-23caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100289252026-03-03U-1731Drug product2018-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001100289252026-03-03U-1732Drug product2018-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001110902802026-03-03U-1731Drug product2021-08-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-001110902802026-03-03U-1732Drug product2021-08-24caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-00196939782026-03-03Drug product2017-11-13caaa826d4ba7…
2026-08-18 06:07:402026-07N021920-00196939792026-03-03Drug product2017-11-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021920-001100223442026-03-03U-1731Drug product2018-07-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100223442026-03-03U-1732Drug product2018-07-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100289252026-03-03U-1731Drug product2018-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001100289252026-03-03U-1732Drug product2018-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001110902802026-03-03U-1731Drug product2021-08-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-001110902802026-03-03U-1732Drug product2021-08-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-00196939782026-03-03Drug product2017-11-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021920-00196939792026-03-03Drug product2017-11-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100223442026-03-03U-1731Drug product2018-07-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100223442026-03-03U-1732Drug product2018-07-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100289252026-03-03U-1731Drug product2018-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001100289252026-03-03U-1732Drug product2018-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001110902802026-03-03U-1731Drug product2021-08-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-001110902802026-03-03U-1732Drug product2021-08-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-00196939782026-03-03Drug product2017-11-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021920-00196939792026-03-03Drug product2017-11-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08N021920-001100223442026-03-03U-1731Drug product2018-07-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100223442026-03-03U-1732Drug product2018-07-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100289252026-03-03U-1731Drug product2018-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001100289252026-03-03U-1732Drug product2018-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001110902802026-03-03U-1731Drug product2021-08-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-001110902802026-03-03U-1732Drug product2021-08-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-00196939782026-03-03Drug product2017-11-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021920-00196939792026-03-03Drug product2017-11-136a471c1ec25d…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fcd4b0bc-1705-4fc2-8c4b-7fd4cc8948ffba87f049-0bac-47fa-adb8-cbce089e407d2020-12-18WarningsExact identifier
spl set id: ba87f049-0bac-47fa-adb8-cbce089e407d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.